25/250 SP 343 (Parcopa 25 mg / 250 mg)
Generic Name: carbidopa/levodopa
Pill imprint 25/250 SP 343 has been identified as Parcopa 25 mg / 250 mg.
Parcopa is used in the treatment of parkinson's disease; restless legs syndrome; neuroleptic malignant syndrome; gtp-ch deficiency and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Parcopa 25 mg / 250 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- 25/250 SP 343
- 25 mg / 250 mg
- 14.00 mm
- Prescription only
- Drug Class:
- Dopaminergic antiparkinsonism agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Schwarz Pharma
- National Drug Code (NDC):
- Inactive Ingredients:
natural mint flavor
artificial mint flavor
FD&C Blue No. 2 Aluminium Lake
|NDC Code||Manufacturer / Repackager|
|18860-0343||Azur Pharma Inc|
Note: Inactive ingredients may vary.
More about Parcopa (carbidopa / levodopa)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.